The abstract is read at the publisher; the summary is JClub's.
Continuing annual breast cancer screening in older Medicare women yields average gains of 4.7–20.5 life-years per 1000 at age 70 and 3.4–13.6 at age 75.
- Why it matters: Stopping screening after age 74 is uncertain, and prior life-years-gained estimates often ignore individualized cancer risk and life expectancy.
- What they did: Using SEER-Medicare (1999–2017), the study emulated individualized benefit by combining screening-associated breast cancer mortality risk reductions with individualized breast cancer and competing mortality risks over 8 years.
- The result: Average life-years gained were lower for women with higher comorbidities/frailty, lowest for Hispanic/Asian/other race, and highest for Black women.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.